Blend10 mg
CJC-1295 / Ipamorelin Blend (10 mg Vial)
Dosing & reconstitution protocol
Quick Reference
VIAL SIZE10 mg (5 mg + 5 mg)
RECONSTITUTION3.0 mL bacteriostatic water
CONCENTRATION3.33 mg/mL total (1.67 mg/mL each)
ROUTESubcutaneous injection
FREQUENCYOnce daily
CYCLE LENGTH8–16 weeks
DOSE RANGE100–300 mcg each peptide daily
STORAGE−20 °C lyophilized / 2–8 °C reconstituted
Overview
Pre-blended CJC-1295 (No DAC) + Ipamorelin for synergistic dual-pathway GH release. At 3.33 mg/mL total, each 0.06 mL delivers ~100 mcg of each peptide.
Dosing & Reconstitution Guide
| Phase | Daily Dose | Units | Volume |
|---|---|---|---|
| Weeks 1–2 | 100 mcg each | 6 units | 0.06 mL |
| Weeks 3–4 | 200 mcg each | 12 units | 0.12 mL |
| Weeks 5–12 | 300 mcg each | 18 units | 0.18 mL |
Reconstitution Instructions
1.
Draw 3.0 mL bacteriostatic water with a sterile syringe.
2.
Inject slowly down the vial wall; avoid foaming.
3.
Gently swirl/roll until dissolved (do not shake).
4.
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
- ✓Blend Vials (CJC/Ipa, 10 mg): 2 vials
- ✓Insulin Syringes (U-100): 56 syringes
- ✓Bacteriostatic Water (10 mL): 2 bottles
- ✓Alcohol Swabs: 112 swabs
Dosing Protocol
Schedule
Inject once daily before bed on an empty stomach (2+ hours after last meal).
Cycle Structure
8–12 weeks, then 4-week break before repeating.
Timing
Before bed to align with natural nocturnal GH pulse.
Storage & Handling
- ✓Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure.
- ✓Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
- ✓Allow vials to reach room temperature before opening to reduce condensation uptake.
- ✓Do not freeze reconstituted solution.
- ✓Discard if solution becomes cloudy or contains visible particles.
Important Notes
- ✓All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.
- ✓Use new sterile insulin syringes for each injection; dispose in a sharps container.
- ✓Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
- ✓Inject slowly; wait a few seconds before withdrawing the needle.
- ✓Document daily dose and site rotation to maintain consistency.